Viewing nowRosutan 5mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

MFDS item code 201502564 · Approved 2015.04.28 · Insurance code 653403160
Improvement of dyslipidemia, inhibition of the progression of atherosclerosis, and prevention of cardiovascular diseases
This medication is primarily used for the treatment of hypercholesterolemia and hyperlipidemia. It is used as an adjunct in patients with primary hypercholesterolemia or mixed hyperlipidemia not adequately controlled by diet and exercise alone. Furthermore, it aids patients with homozygous familial hypercholesterolemia and dysbetalipoproteinemia as a supplement to dietary therapy. This drug lowers total cholesterol and LDL cholesterol levels, effectively slowing the progression of atherosclerosis. It is also suitable for pediatric patients aged 10 to 17 years with familial hypercholesterolemia and is used to reduce the risks of stroke, myocardial infarction, and arterial revascularization in adults at high risk of cardiovascular disease. Overall, this medication helps improve lipid levels and maintain cardiovascular health.
1. Primary hypercholesterolemia (including heterozygous familial hypercholesterolemia, type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving or about to receive this medicine should follow a standard cholesterol-lowering diet and continue it throughout treatment. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; for patients requiring a greater reduction in LDL cholesterol, the dose may be adjusted as a maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, and may be increased to a maximum of 20 milligrams once daily. 3. Elderly patients : No dose adjustment is necessary. 4. Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment : No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race : Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40 milligrams dose is contraindicated. 7. Patients predisposed to myopathy : The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40 milligrams dose is contraindicated in some of these patients.
Ages 10 to 17 years: The usual dose range is 5 milligrams to 20 milligrams once daily. (There are no clinical data on doses higher than 20 milligrams in pediatric patients.) Under 10 years of age: Safety and efficacy have not been established.
This medication should not be used in certain patients. Patients who are allergic to any component of this medication should not take it. Patients with severely impaired liver function or liver disease may be at risk if they use this medication. Patients with muscle disorders or issues with muscles should avoid this drug. Patients taking the immunosuppressant cyclosporine should also refrain from using this medication. Patients with severely impaired kidney function should not take this medication, nor should pregnant or breastfeeding women. Women of childbearing potential should use reliable contraception and can only use this medication if they are fully aware of the risks to the fetus. High-dose use is prohibited for patients at high risk of muscle-related side effects. Patients with genetic metabolic disorders such as lactose intolerance should also avoid this medication. Additionally, patients with a history of liver disease or those who consume excessive alcohol should undergo regular liver function tests while using this medication. If symptoms such as muscle pain or weakness occur, it is important to inform medical personnel immediately, and the use of the medication should be discontinued if necessary. Patients at risk of muscle damage should undergo blood tests before and during treatment to monitor their muscle condition. The use of this medication should be suspended in cases of acute severe illness or conditions at risk for rapid deterioration of kidney function. This medication can rarely cause severe muscle weakness, so if such symptoms appear, the use should be halted immediately. This medication may interact with other drugs, so it is essential to inform your doctor or pharmacist if you are taking other medications. Particularly, caution is needed when combined with specific antiviral agents, immunosuppressants, antibiotics, and lipid-lowering agents that increase the risk of muscle damage. Pregnant or breastfeeding women should not use this medication, and women of childbearing potential must practice appropriate contraception. In cases of overdose, as there is no specific antidote, immediate medical treatment is necessary, and liver function and muscle damage should be assessed. This medication is not believed to significantly impact driving or operating machinery, but caution is advised as dizziness may occur. This medication can rarely lead to serious skin reactions or liver damage, so if symptoms such as skin rash or jaundice occur, the use should be discontinued immediately and a doctor should be consulted. Overall, routine check-ups and prompt responses to any abnormal symptoms are crucial for the safe use of this medication.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, shortness of breath, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome, lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal hepatic failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is best to store the medication at room temperature between 1 to 30 degrees Celsius, away from extremes of heat and cold.
Yellow round film-coated tablet
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Dongkuk Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.